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PhosphorylationCalcineurin is a phosphatase that is activated at the last known stage of mitosis, abscission. Among its many
substrates, it dephosphorylates dynamin II during cytokinesis at the midbody of dividing cells. However,
dynamin II has several cellular roles including clathrin-mediated endocytosis, centrosome cohesion and
cytokinesis. It is not known whether dynamin II phosphorylation plays a role in any of these functions nor
have the phosphosites involved in cytokinesis been directly identiﬁed. We now report that dynamin II from
rat lung is phosphorylated to a low stoichiometry on a single major site, Ser-764, in the proline-rich domain.
Phosphorylation on Ser-764 also occurred in asynchronously growing HeLa cells and was greatly increased
upon mitotic entry. Tryptic phospho-peptides isolated by TiO2 chromatography revealed only a single
phosphosite in mitotic cells. Mitotic phosphorylation was abolished by roscovitine, suggesting the mitotic
kinase is cyclin-dependent kinase 1. Cyclin-dependent kinase 1 phosphorylated full length dynamin II and
Glutathione-S-Transferase-tagged–dynamin II–proline-rich domain in vitro, and mutation of Ser-764 to
alanine reduced proline-rich domain phosphorylation by 80%, supporting that there is only a single major
phosphosite. Ser-764 phosphorylation did not affect clathrin-mediated endocytosis or bulk endocytosis using
penetratin-based phospho-deﬁcient or phospho-mimetic peptides or following siRNA depletion/rescue
experiments. Phospho-dynamin II was enriched at the mitotic centrosome, but this targeting was unaffected
by the phospho-deﬁcient or phospho-mimetic peptides. In contrast, the phospho-mimetic peptide displaced
endogenous dynamin II, but not calcineurin, from the midbody and induced cytokinesis failure. Therefore,
phosphorylation of dynamin II primarily occurs on a single site that regulates cytokinesis downstream of
calcineurin, rather than regulating endocytosis or centrosome function.+61 2 9687 2120.
.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Dynamin II (dynII) is a large GTPase enzyme that is essential for
clathrin-mediated endocytosis (CME). It also plays roles in centrosome
cohesion and cytokinesis [1–4]. It is one of three “classical” dynamins
(I, II and III) and with a variety of dynamin-related proteins (DRPs)
forms the dynamin super family, which is conserved throughout
eukaryotes [5]. All members appear to be involved in membrane
ﬁssion or fusion events. DynI is neuron-speciﬁc, dynII is ubiquitously
expressed and dynIII has restricted expression primarily in brain and
testis [6]. DynII appears to be the ancestral formmost closely related to
the DRPs found in lower organisms. All dynamin super family proteins
contain an N-terminal GTPase domain and a middle domain, while
most also have a GTPase effector domain (GED). Interaction between
these domains allows for dynamin oligomerisation [7]. The classicaldynamins contain two additional domains: a pleckstrin homology
(PH) domain for phospholipid binding and a proline-rich domain
(PRD) that is the main site of phosphorylation and interacts with SH3
domains from other proteins [8].
DynI and dynIII are phosphorylated in nerve terminals on Ser-774
and Ser-778 (equivalent to Ser-759 and Ser-763 in dynIII) in the
phospho-box region of their PRD [9]. DynI is phosphorylated on these
sites in vitro by the cyclin-dependent kinase (cdk), cdk5 [8] and on
Ser-857 by minibrain kinase/Dyrk1A [10]. In addition, we used mass
spectrometry to conﬁrm Ser-857 as well as identify Ser-512, Ser-851,
Ser-822 and Ser-347 as in vivo phosphosites [9]. Whereas dynIII is
phosphorylated on only one additional phosphosite, Ser-853, which is
equivalent to Ser-851 in dynI [9]. When nerve terminals are
depolarised, the resultant Ca2+-inﬂux activates CaN to dephosphor-
ylate dynI [11] and immediately stimulates activity-dependent bulk
endocytosis (ADBE) for later formation of new synaptic vesicles by
budding from the endosomes [6,12]. These phosphosites regulate
protein–protein interactions: Ser-774/Ser-778 dephosphorylation
stimulates syndapin recruitment [13,14], whereas Ser-857
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(amphI) and Grb2, although it is not located within their known
binding site [10]. The roles of the other dynI sites or the three
phosphosites in dynIII are unknown.
In non-neuronal cells, overexpressed dynI and endogenous dynII
are phosphorylated by the tyrosine kinase c-Src at Tyr-231 and Tyr-
597 following growth factor stimulation [15,16] and this appears to
regulate Golgi integrity and vesicle secretion from the Golgi [17].
Previous systematic phosphosite analysis experiments in nerve
terminals revealed no in vivo phosphorylation sites identiﬁed in rat
brain dynII, despite that the protein was readily isolated and detected,
indicating that it is not appreciably phosphorylated in nerve terminals
despite good protein abundance [9]. Of the seven dynI phosphoryla-
tion sites in rat brain, only two are conserved in the dynII amino acid
sequence, Ser-347 and Ser-778. This corresponds to rat/human dynII
amino acids Ser-347 and Ser-764. Ser-347 phosphorylation accounts
for b2% of total dynI phosphorylation and is not dephosphorylated
following depolarisation, suggesting it is not a major player in
regulating dynI function for ADBE [9]. In contrast, Ser-778 is one of
the two major phosphorylation sites that are dephosphorylated
following depolarisation. The analogous site, Ser-764, in the dynII
phospho-box region is located within a predicted amino acid
consensus motif for potential phosphorylation by cdks.
We recently reported that CaN activity is required for cytokinesis
and that dynII is one of its substrates at the midbody [18]. DynII is
required for the abscission phase of cytokinesis which is delayed or
blocked in the presence of small molecular inhibitors and siRNA
targeting dynII [4]. A recent manuscript indicated that dynII is
phosphorylated by Cdk1/cyclin B1 on Ser-764 and/or Thr-766 during
mitosis and that this reduces its ability to bind microtubules [19]. The
role of dynII phosphorylation in cytokinesis is unknown. At least three
other endocytic proteins are mitotically phosphorylated by cdk,
including epsin, eps15 and amphiphysin I [20,21] of which all are
CaN targets in nerve terminals [6]. Two large-scale phosphoproteomic
screens identiﬁed additional endocytic proteins (e.g. synaptojanin,
clathrin light chain) that may be mitotically phosphorylated in HeLa
cells [22,23]. This raises the question of whether phosphorylation of
endocytic proteins during mitosis affects their endocytic and/or
mitotic functions. However, shotgun phosphoproteomic screening
data require validation of each protein and phosphosite, as the false
discovery rate of assigning the correct phosphosite to a peptide is
often unacceptably high. Therefore, our ﬁrst aim was to use several
approaches to directly identify the in vivo dynII serine/threonine
phosphorylation sites and to conﬁrm which are genuine in vivo
mitotic phosphosites. We found that it is mitotically phosphorylated
by cdk1 in HeLa cells at a single detectable site in the phospho-box,
Ser-764. We then aimed to reveal the role of dynII–Ser-764
phosphorylation during mitosis since the analogous site in dynI
controls endocytosis. Surprisingly, phosphorylation was not involved
in CME or centrosome localisation but speciﬁcally targets dynII to the
midbody and is involved in cytokinesis.
2. Materials and methods
2.1. siRNA and plasmid construction
Stealth siRNAs targeting human dynamin (dyn, 5′-UCUCCUGCCG-
GACUUCAUCAAAGUC-3′) and luciferase (luc, 5′-CGUACGCGGAAUA-
CUUCGATT-3′) were purchased from Invitrogen. GFP-α-tubulin was
obtained from Jenny Stow (Institute for Molecular Biosciences,
Australia). A rat dynamin II cDNA encoding the “aa” splice variant
was isolated from a brain cDNA library (Invitrogen) and cloned into
pEGFP-C1 as an EcoRI and BamHI fragment to generate GFP–dynIIwt.
The proline-rich domain (PRD) of rat dynII was ampliﬁed using GFP-
dynIIwt as a template, then cloned into pGEX-1λT as a BamHI
fragment to generate wild-type GST–dynII–PRD (amino acids 740–870). Phospho-deﬁcient (Ser-764A and Ser-764A/T766A) and phos-
pho-mimetic (Ser-764E and Ser-764E/T766E) mutant forms of GFP–
dynII (full length and PRD) and a phospho-deﬁcient (Ser-764A) form
of GST–dynII–PRD were generated using the QuickChange site-
directed mutagenesis kit (Stratagene). The identity of plasmid
constructs were conﬁrmed by sequencing and details of primers are
available upon request. GST–human amphiphysin II (amphII)–SH3
domain (residues 499–593), in a pGEX-2T plasmid as described [24],
GST–rat dynII–PRDwt (amino acids 740–870) and GST–dynII–PRD–
Ser-764A fusion proteins were expressed in Escherichia coli and
puriﬁed using glutathione-sepharose beads (Amersham Biosciences)
according to the manufacturer's instructions.
2.2. Cell culture and transfection
HeLa cells were maintained in RPMI 1640 medium supplemented
with 10% foetal bovine serum (FBS) and grown at 37 °C in a
humidiﬁed 5% CO2 atmosphere. Cells were seeded at 50%–60%
conﬂuence and transfected with the 1.5 μg of the indicated GFP-
tagged plasmid/well of a 6-well plate using Lipofectamine 2000
(Invitrogen) according to the manufacturer's instructions. For siRNA
analysis, HeLa cells were transfected with 1000 pmol of siRNA (per
10 cm2 dish) using Lipofectamine 2000 (Invitrogen). Cells were
collected ﬁve days post-transfection for immunoblotting. For siRNA
rescue assays, cells (2.5×105) were co-transfected with 200 pmol of
siRNA (against human dynII) and 1.2–1.4 μg of the indicated plasmid
DNA (from rat dynII) using 4 μl of Lipofectamine 2000 (Invitrogen)
following themanufacturer's general protocol. This rat dynII sequence
varies in 6 positions from the human siRNA target region sequence,
making it immune from the siRNA treatment. Cells were trypsinized
and re-seeded at 48 h after transfection then assayed for transferrin
(Tfn) uptake the following day.
2.3. Cell synchronisation and treatments
Cells grown on coverslips were synchronised at the G1/S border by
double thymidine block. Cells were then released into the cell cycle
following thymidine wash-out as previously described [25]. At 8 h
post-release cells were treated with 100 μM of the dynII peptide for
10 h then ﬁxed for immunoﬂuorescence microscopy analysis. For
mitotic synchronization, cells were treated with 0.5 μg/ml nocodazole
for 16 h. Mitotic arrested cells were collected by “mitotic shake-off”
for immunoblot analysis. For cdk inhibition, cells were treated with
10 μM roscovitine either alone or in combination with nocodazole.
Under these conditions only mitotically rounded cells were collected
and analysed. Alternatively, cells were synchronised at the G2/M
border by treatment with the selective cdk1 small-molecule inhibitor,
RO-3306 (9 μM) for at least 18 h [26]. Cells were allowed to progress
through mitosis following RO-3306 wash-out. Where indicated, cells
were treated with 100 μM of the dynII peptide immediately following
RO-3306 wash-out and incubated at 37 °C/5% CO2 for 1.5 h (meta-
phase localization analysis), 3 h (cytokinesis localization analysis) or
6 h (multinucleation scoring).
2.4. Antibodies
The following antibodies were used: anti-dynII (C-18, Santa Cruz
Biotechnology), anti-dynI, anti-dynI phospho-Ser-774 and anti-dynI
phospho-Ser-778 [13], anti-cyclin B1 (V152; Cell Signaling), anti-α-
tubulin (clone DM1A; Sigma) and anti-γ-tubulin (GTU88; Sigma).
2.5. Immunoblotting
Cellular extracts were prepared by incubating HeLa cells in ice-
cold lysis buffer (25 mM Tris–HCl pH 7.4, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1 mM PMSF, 1% Triton X-100, and EDTA-free Complete
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collected following centrifugation at 13,000 rpm for 30 min at 4 °C.
DynII protein was enriched by incubating the cellular extracts with
puriﬁed GST–amphII–SH3 domain bound to glutathione-sepharose
beads for 1 h at 4 °C. Beads were washed extensively with ice-cold
lysis buffer. Bound proteins were fractionated by SDS–PAGE for
immunoblot analysis. Primary antibody was applied then detected by
with a horseradish peroxidase-conjugated secondary antibody
(Sigma). Blotted proteins were visualised using the ECL detection
system (Pierce).
2.6. Antarctic phosphatase treatment
For dephosphorylation, mitotic HeLa cell lysates were prepared
and the sample was enriched for dynII protein by performing a pull-
down with 100 μl of a 50% slurry of GST–amphII–SH3 as described
above. Beads were washed twice with ice-cold wash buffer (20 mM
ammonium bicarbonate, pH 8.0), then resuspended in ice-cold
reaction buffer (20 mM ammonium bicarbonate, 1 mM MgCl2, pH
8.0). Antarctic phosphatase (AP, 5 μl, New England Biolabs)was added
and the reaction was incubated for 2 h at 15 °C before the beads were
washed to remove the phosphatase.
2.7. In vitro protein phosphorylation
DynI was puriﬁed by a GST–amphII–SH3 pull-down from total
sheep brain extract, as described previously for rat brain [13]. DynII
(100 μg) was puriﬁed from baculovirus-infected Sf9 insect cells
(provided by SL Schmid, the Scripps Research Institute, CA) but had a
high level of endogenous phosphorylation that required prior
removal. DynI and dynII were diluted in Tris buffer (20 mM Tris–
HCl pH 7.4, 1 mM DTT, 150 mM NaCl and EDTA-free Complete
protease inhibitor cocktail), bound to GST–amphII–SH3 beads,
washed twice and incubated overnight with AP at 4 °C and depho-
sphorylated dynI and dynII were eluted twice with Tris–HCl buffer
containing 1.2 M NaCl. The eluted fractions were pooled and micro-
dialysed (Pierce) against Tris buffer containing 20% glycerol and
100 mM NaCl. Dephosphorylated native dynI and dephosphorylated
baculovirus expressed dynII were then used as in vitro substrates for
puriﬁed recombinant cdk1/cyclin B1, cdk1/cyclin A, cdk2/cyclin A,
cdk2/cyclin E, cdk4/cyclin D1 and MAPK kinase as described
previously [27]. Where indicated, puriﬁed recombinant pRb and
dynII puriﬁed from rat liver were used as substrates. Alternatively,
puriﬁed bacterially expressed wild-type and phospho-deﬁcient (Ser-
764A) forms of GST–dynII–PRD were used as substrates for cdk1/
cyclin A.
2.8. Nano-liquid chromatography mass spectrometry (nanoLC–MSMS)
Lungs were excised from two rats or 107 mitotic synchronised
HeLa cells were used to make lysates from which dynII protein was
enriched by performing a GST–amphII–SH3 pull-down as described
above. Proteins were resolved by SDS–PAGE and visualised on the gel
by staining with colloidal Coomassie blue. DynII SDS–PAGE gel bands,
estimated at 1–5 pmol protein from human mitotic cells or 10–
20 pmol from rat lung, were digested with trypsin and phospho-
peptides were enriched using titanium dioxide as described previ-
ously [28]. The rat lung dynII tryptic digest was further digested with
Asp-N because the tryptic phospho-box peptide was considered too
long for correct assignment of the phosphorylation site. An aliquot of
the phospho-peptide-enriched human or rat dynII digest was injected
into a nano-HPLC system (LC Packings Ultimate HPLC system, Dionex,
Netherlands) and the eluate was analysed by a QSTAR XL quadrupole-
TOF MS (Applied Biosystems, USA) or QTOF Premier (Waters, UK) as
described previously [29]. Spectra were recorded using information-
dependent data acquisition. Phosphopetide tandem mass spectrawere exported to Mascot 2.2 (Matrix Science, UK) for automated
database searching and identiﬁcation. They were also manually
examined to determine the phosphorylation sites.
2.9. Immunoﬂuorescence microscopy
Cells were ﬁxed in ice-cold 100% methanol for 10 min at −20 °C
and then blocked in 3% bovine serum albumin/PBS for 45 min before
the required primary antibody was applied. Cells that were trans-
fected with GFP–dynII–PRD plasmids were ﬁxed in 4% paraformal-
dehdye/PBS. Fluorescein- or Texas Red dye-conjugated AfﬁniPure
secondary antibodies (Jackson ImmunoResearch Laboratories, Inc.)
were then applied. Cell nuclei were counterstained with DAPI (4′, 6′-
diamidino-2-phenylindole; Sigma). Cells were washed three times
with PBS between each step except after blocking. Cells were viewed
and scored with a ﬂuorescence microscope (Ziess). Fluorescence
images were captured under an Olympus IX80 inverted microscope
using 100× oil immersion lenses and deconvolved using AutoDeblur
v9.3 (AutoQuant Imaging, Watervliet, NY).
2.10. Endocytosis assay
Quantitative high-throughput receptor-mediated endocytosis
(RME) assays were performed by an automated process as previously
described [30,31] using Texas Red-Transferrin (Tfn), Texas Red-
epidermal growth factor (EGF), and FITC-dextran uptake in cultured
U2OS and HeLa cells pretreated with penetratin-coupled dynII
peptides for 30 min. IC50 values were calculated using Prism 5
(GraphPad Software Inc.) and data are expressed as mean±95%
conﬁdence intervals (CI) for triplicates and ~1200 cells.
3. Results
3.1. DynII phosphorylation at Ser-764 by cdk1/cyclin B1
Of the two main dynI phosphosites (Ser-774 and Ser-778), only
Ser-778 is conserved in the dynII phospho-box at position Ser-764
(Fig. 1A), but this site is not detectably phosphorylated in dynII from
nerve terminals [9]. Ser-764 precedes a proline residue. Therefore, we
used in vitro protein kinase phosphorylation assays to ask whether a
cdk could phosphorylate dynII–Ser–764. DynII was phosphorylated in
vitro by cdk1/cyclin A, cdk1/cyclin B1, cdk2/cyclin A and cdk2/cyclin E
complexes with similar efﬁciency using [γ-
32
P]ATP labelling (Fig. 1B
and D). This phosphorylation was speciﬁc, as Cdk4/cyclin D1 did not
phosphorylate dynII yet was fully active on a reference substrate—Rb
protein (Fig. 1D). Another proline-directed kinase, mitogen-activated
protein kinase (MAPK), also phosphorylated both dynamin proteins
to a lesser extent (Fig. 1B and C). To determine if dynII–Ser-764 was a
site of phosphorylation we used a phospho-speciﬁc antibody. The
phospho-peptide amino acid sequence used to generate the dynI
phospho-Ser-778 antibody is conserved in dynII (underlined in
Fig. 1A) except for the single N-terminal residue. We have previously
shown that this antibody recognises dynII phosphorylated at Ser-764
[18]. This antibody recognised cdk1-mediated phosphorylated dynII
in vitro, indicating that cdk targets Ser-764 (Fig. 1B). As a control, dynI
was phosphorylated on Ser-778 in vitro by both cdk1/cyclin A and
cdk1/cyclin B1 as indicated by both [γ-
32
P]ATP labelling and Western
blot analysis with the phosphosite-speciﬁc antibody (Fig. 1C),
consistent with previous reports [8]. Phosphorylation detected by
both [γ-
32
P]-ATP labelling and the phosphosite-speciﬁc antibody
matched for each protein kinase, suggesting dynII is phosphorylated
on the analogous site, Ser-764 in the PRD. This was conﬁrmed by MS
analysis (see below).
We next aimed to determine whether other phosphosites were
targeted by cdk1 in the dynII PRD. As found for full length dynII
(Fig. 1B), GST–dynII–PRDwt protein was efﬁciently phosphorylated
Fig. 1. DynII is phosphorylated by the mitotically active kinase, cdk1/cyclin B1 on Ser-764. (A) Dynamin consists of four major domains: the GTP hydrolysis domain (GTPase),
a pleckstrin homology (PH) domain, a GTPase effector domain (GED) and a proline-rich domain (PRD). DynI is phosphorylated by cdk5 at Ser-774 and Ser-778 (bold amino
acids) in vivo in the ‘phospho-box’ region. Of these two phosphorylation sites, only Ser-778 is conserved in dynII as an SP motif, corresponding to residue Ser-764 (bold). The
amino acid sequence underlined in dynI was the peptide used to generate the phospho-Ser-778 speciﬁc antibody [13]. (B and C) In vitro protein kinase assay. Puriﬁed cdk1/
cyclin A, cdk1/cyclin B1 and MAPK were examined for their ability to phosphorylate puriﬁed dynII and dynI at Ser-764 and Ser-778, respectively, in an in vitro protein kinase
assay. DynII (B) and dynI (C) phosphorylation were determined by [γ-
32
P]-ATP labelling (upper panel) and Western blotting (middle panel) with the phospho-speciﬁc
antibody anti-dynI–Ser-778. (D) In vitro phosphorylation of dynII by Cdk/cyclin complexes. Puriﬁed cdk1/cyclin A, cdk1/cyclin B1, cdk2/cyclin A, cdk2/cyclin E and cdk4/cyclin
D1 kinases were examined for their ability to phosphorylate dynII, which had been puriﬁed from rat liver (0.1 μg, lanes 1–6) and from baculovirus (0.5 μg, Sf9 cells; lanes 7–
12) in an in vitro protein kinase assay. Rb (2 μg) was phosphorylated with the same kinases (lanes 13–18) and served as a positive control. Phosphorylation was determined
by [γ-
32
P]ATP labelling. DynII was phosphorylated by all cdk/cyclin protein kinase complexes except for cdk4/cyclin D1. Blots shown in (B–D) are representative of at least
two independent experiments.
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32
P]-ATP labelling and phosphorylation
increased in a time-dependent manner (Fig. 2). Phosphorylation was
greatly reduced when Ser-764 was mutated to alanine (Fig. 2). Lessthan 20% of the total phosphorylation remained in this mutant,
suggesting that Ser-764 is the major in vitro phosphorylation site by
cdk1 within the dynII–PRD.
Fig. 2.Mutation of Ser-764 reduces cdk1-mediated phosphorylation of dynII in vitro. GST–dynII–PRDwt was phosphorylated by cdk1/cyclin A as determined by [γ-
32
P]-ATP labelling
and this increased with time. Cdk1/cyclin A-mediated phosphorylation was signiﬁcantly reduced by mutation of Ser-764 to alanine. NK, no kinase. The upper panels are
autoradiographs (
32
P) of phosphorylated GST–dynII–PRDwt (left) or GST–dynII–PRD—S764A (right), with the corresponding Coomassie stained gels in the panels below
(Coomassie). Blots are representative of two independent experiments.
Fig. 3.DynII is phosphorylated at Ser-764 duringmitosis. (A) Asynchronous andmitotically synchronised HeLa cells were treated with the cdk inhibitor, roscovitine (10 μM) for 16 h.
Whole cell lysates (100 μg) were blotted for the phosphorylation status of dynII at Ser-764 and for dynII levels. (B) Lysates from HeLa cells synchronised in prometaphase were
treated with or without Antarctic phosphatase (AP). DynII puriﬁed from baculovirus-infected Sf9 cells served as a control. Samples were blotted for the phosphorylation status of
dynII and for dynII levels. Blots shown in panels A and B are representative of three independent experiments. (C) Native dynII was puriﬁed from rat lung and doubly digested with
trypsin followed by Asp-N. Analysis of the titanium dioxide enriched fraction of this digest revealed a single phospho-peptide that was sequenced by tandem mass spectrometry.
Fragmentation of the triply charged precursor at m/z 626.6 produced a spectrum matching the sequence of rat dynII754–769 where Ser-764 is phosphorylated (shown as pS). The
phosphorylation site was readily revealed as the molecular mass of a dehydroalanine residue (69 Da) between y5 and y6-98 ions resulting from the neutral loss of phosphoric acid
(−98 Da) from the phosphoserine residue. (D) Phosphorylated dynII was isolated from mitotically synchronised HeLa cells. A single phosphorylated tryptic peptide was found and
its phosphorylation site was sequenced by tandem mass spectrometry. Fragmentation of the quadrupally charged precursor at m/z 1046.3 produced a spectrum matching the
sequence of human dynII731–769 where Ser-764 is phosphorylated. Although this peptide was longer than the rat dynII peptide, the fragmentation information from the C-terminal
end was the same. The phosphorylation site was unequivocally revealed between the y5 and y6-98 ions.
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Several components of the endocytic machinery are mitotically
phosphorylated—epsin, eps15 [20], amphiphysin [21] and Drp1 [32].
Since dynII is phosphorylated by the mitotic kinase, cdk1/cyclin B1,
and dephosphorylated by CaN during cytokinesis [18], we asked
whether phosphorylation is increased during mitosis in HeLa cells.
DynII phosphorylation at Ser-764 was barely detectable in asynchro-
nously growing cells but was markedly increased in mitotically
synchronised cells (Fig. 3A). This was prevented by treatment with
the cdk inhibitor, roscovitine (Fig. 3A), suggesting that cdk1 is the
responsible in vivo protein kinase. The dynI phospho-Ser-774
antibody did not recognise any HeLa cell proteins in the 90–110 kDa
region, consistent with undetectable expression of dynI in these cells
(data not shown) and lack of conservation of Ser-774 in the dynII
sequence (Fig. 1A). Antarctic phosphatase treatment of lysates from
mitotically synchronised HeLa cells abolished phospho-Ser-778
antibody labelling (Fig. 3B), conﬁrming that the band detected during
mitosis represented bona ﬁde dynII phosphorylation. Thus, Ser-764 on
dynII is mitotically phosphorylated.
3.3. Identiﬁcation of Ser-764 phosphorylation by mass spectrometry
We used comprehensive mass spectrometry analysis of dynII to
determine the number and site(s) of phosphorylation on dynII. Tandem
mass spectrometry on aQTOF Premier (Waters, UK) revealed that nativeFig. 4. Ser-764 phosphorylation is not required for endocytosis. (A) Sequences of penetrati
throughput endocytosis assays were performed by an automated process using Texas Red-Tf
with the dynII peptides for 30 min. Data are expressed as mean±95% conﬁdence intervals
experiments. (E) Quantitation of the percentage of HeLa cells that have endocytosed Texas R
indicated rat GFP–dynII plasmid. DynII–Ser-764 phospho-deﬁcient and phospho-mimetic mdynII puriﬁed from two rat lungs was phosphorylated on a single site in
vivo at Ser-764 (Fig. 3C). This identiﬁcation required a large amount of
tissue and extracted dynII to be detectable, thus, is likely to be very low
stoichiometry. To directly identify the mitotic phosphorylation site in
human dynII, the protein was enriched from mitotically synchronised
HeLa cells by binding to GST–amphII–SH3 attached to GSH sepharose,
which quantitatively binds all three classical dynamins [9]. Tryptic
digests analysed by tandem mass spectrometry exclusively detected
dynII, conﬁrming the lack of detectable expression of dynI or III in these
cells. In at least six independent experiments, a single phospho-peptide
was found and the site was assigned to Ser-764 in dynII (Fig. 3D). At no
point were other phospho-peptides or phosphosites identiﬁed.
3.4. Phosphorylation at Ser-764 is not required for clathrin-mediated
and bulk endocytosis
To gain insight into the biological signiﬁcance of dynII–Ser-764
phosphorylation, we sought to determine its effect on endocytosis by
using a penetratin-based membrane permeable peptide strategy
[12,13,33]. Phospho-mimetic peptides were designed to mimic the
amino acid sequence of the dynII phospho-box andwere taggedwith a
short penetratin heptapeptide to facilitate their delivery into cells
(Fig. 4A). This strategy prevents indirect or long-termeffects caused by
overexpressing dynII phosphosite mutants and avoids variability in
transfection efﬁciency. It has been validated in several previous
studies, such as in determining the role of dynI dephosphorylation inn-linked peptides synthesised from the phospho-box region. (B–D) Quantitative high-
n (B), Texas Red-EGF (C) and FITC-dextran (D) uptake in cultured U2OS cells pretreated
(CI) for triplicates and ~1200 cells. Similar results were obtained in three independent
ed-Tfn following co-transfection with the indicated siRNA and either GFP-tubulin or the
utants rescue endocytosis of Tfn as efﬁciently as wild-type GFP–dynII.
Fig. 5. Ser-764 phosphorylation is not required for targeting dynII to the mitotic
centrosome. (A) Phospho-dynII localises to the mitotic centrosome. Asynchronously
growingHeLa cells were stained for endogenous phospho-dynII–Ser-764 (green) and total
dynII protein (red). Representative cells from different stages of mitosis are shown,
illustrating phosphorylated dynII initially at the mitotic centrosome and later at the
midbody during cytokinesis. The position of phospho-dynII is shown with arrows (all
panels). (B) Representative microscopy images of HeLa cells in metaphase treated in the
absence and presence of the DynII-AA and DynII-EE peptide. Phospho-dynII–Ser-764
mitotic centrosome localisation isnotdisruptedby treatmentwith eitherpeptide.γ-tubulin
(red) served as an independent centrosome marker.
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studies, the homologous phospho-box AA peptide designed against
the sequence of dynI (Fig. 4A) potently inhibits ADBE by preventing
the dynI/syndapin I interaction,while it iswithout effect on transferrin
endocytosis in U2OS cells which lack dynI. Thus, it was possible that
the analogous dynII peptide would inhibit CME. However, neither the
dynII759–775EE phospho-mimetic peptide nor the dynII759–775AA
phospho-deﬁcient peptide had signiﬁcant effects on endocytosis of
transferrin (Fig. 4B) or EGF (Fig. 4C) in U2OS cells. Only at extremely
high concentrations was endocytosis of transferrin slightly inhibited;
however, this was not signiﬁcant. Endocytosis of dextran, the ﬂuid
phase-marker of bulk endocytosis, was also not affected by either dynII
phospho-peptide (Fig. 4D). Similar ﬁndings were observed in HeLa
cells (Supplementary Fig. 1). This suggests that Ser-764 phosphory-
lation does not regulate the endocytic function of dynII.
To independently ask whether there is a role for Ser-764 in
endocytosis, we performed a rescue experiment following depletion
of dynII by siRNA. An siRNA sequence common to human dynI, II and III
resulted in N90% depletion of dynII and a block in endocytosis of
transferrin (data not shown and Fig. 4E). We aimed to rescue this
phenotype by overexpressing rat GFP–dynII since the rat sequence
varies in 6 positions from the human siRNA target region sequence and
is resistant to the siRNA treatment. Ectopic expression of wild-type rat
GFP–dynII completely restored endocytosis (Fig. 4E). In contrast, endo-
cytosis was not restored in cells expressing GFP-α-tubulin. Consistent
with the results obtained with the phospho-peptide strategy, endo-
cytosis was completely restored in cells ectopically expressing either
the phospho-deﬁcient (Ser-764A/Thr-766A) or phospho-mimetic
(Ser-764E/Thr-766E) forms of GFP–dynII (Fig. 4E). This indicates
that Ser-764 phosphorylation is not required for the endocytic func-
tion of dynII. Thus, dynII–Ser-764 phosphorylation may be speciﬁcally
involved in a mitosis-speciﬁc role that is independent of endocytosis.
3.5. DynII localisation to the mitotic centrosome is not dependent on
Ser-764 phosphorylation
DynII has been implicated in centrosome cohesion [3] and
cytokinesis [1,2,4,34,35]. The centrosome is a critical component for
mitosis as it forms the poles of the mitotic spindle. DynII localises to
the interphase centrosome and participates in centrosome cohesion
[3]. We now show by immunostaining with the dynII–Ser-764
phospho-speciﬁc antibody that dynII locates to the mitotic centro-
some and is primarily in the phosphorylated form (Fig. 5A). As cells
progress through mitosis (metaphase to anaphase/telophase) phos-
pho-dynII remains associated with the centrosome until a late stage,
cytokinesis (see below). Centrosomal localisation of phospho-dynII
was not disrupted by the dynII759–775EE or dynII759–775AA peptides
(Fig. 5B). Therefore Ser-764 phosphorylation appears not to target or
tether dynII to the mitotic centrosome. Unfortunately, attempts to
address this question by transfection with GFP-tagged dynII were
unsuccessful since, in contrast to native dynII, none of our ectopically
expressed proteins (wt, S764A or S764E; C-terminal GFP-tagged
dynII, N- or C-terminal FLAG-tagged dynII) were associated with the
centrosome possibly due to different expression levels, processing or
subcellular distribution. Despite this, a GFP-tagged middle domain of
dynII did localise at the centrosome as previously observed [3],
supporting our ﬁndings that the PRD is not required for centrosome
tethering. Thus, full length GFP-dynII does not always mimic the
behaviour of endogenous dynamin in all roles.
3.6. Ser-764 phosphorylation is associated with dynII midbody
localisation and cytokinesis
CaN and phospho-dynII localise to the midbody during cytokinesis
[18] and both are required for the abscission stage of cytokinesis
[1,2,4]. The phosphatase activity of CaN is speciﬁcally associated withcompletion of cytokinesis and dynII is one of its substrates [18]. Thus,
we next asked whether this involves dynII–Ser–764 phosphorylation
since phospho-dynII is enriched at the midbody 2.5 h after the onset
of mitosis [18]. We now show that midbody localisation was
unaffected by treatment with the phospho-deﬁcient peptide
(Fig. 6A). In contrast, phospho-dynII was undetectable at themidbody
Fig. 6. Phospho-dynII localises to the midbody. (A and B) Representative immunoﬂuorescence microscopy images of HeLa cells treated with the phospho-deﬁcient or phospho-
mimetic dynII peptides, then stained for phospho-dynII (A) and γ-tubulin (B, upper panels) and CaN (B, lower panels). Phospho-dynII staining is enriched at the midbody (not
shown; [18]) and this was not affected by the phospho-deﬁcient peptide, dynII759–775AA (left). However, the phospho-mimetic peptide, dynII759–775EE, prevents phospho-dynII
recruitment to the midbody (red; two examples are shown on the right) without affecting the localisation of the midbody components, γ-tubulin and CaN. (C) The dynII759–775EE
phospho-mimetic peptide causes cytokinesis failure. HeLa cells were synchronised at the G1/S transition by double thymidine block. At 8 h post-release from the block, cells were
incubated in the presence or absence of either penetratin phospho-box peptide (100 μM). Cells were subsequently stained for α-tubulin and phospho-dynII. The graph displays the
mean±SD from at least two independent experiments. (D) HeLa cells were synchronised at the G2/M transition using RO-3306. Immediately following release from this block, cells
were incubated for 6 h in the presence or absence of a penetratin phospho-box peptide (100 μM) whereby only the Ser-764 is mutated (dynII759–775AT and dynII759–775ET). Cells
were subsequently stained for α-tubulin. The graph displays the mean±SD from two independent experiments. (E) HeLa cells ectopically expressing wild-type, phospho-mimetic
(S764E and S764/T766E) and phospho-deﬁcient (S764A and S764/T766A) mutants of GFP–dynII–PRD were ﬁxed 72 h post-transfection, stained for α-tubulin and scored for
multinucleation. The graph displays the mean±SD from at least two independent experiments.
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(Fig. 6A, upper panels). CaN and γ-tubulin midbody localisation was
unaffected (Fig. 6B, lower panels). This suggests that phospho-dynII
localization to the midbody is dependent in its phosphorylation
status, while CaN localization to the midbody is not dependent on
dynII. Again, full length GFP–dynII did not target the midbody when
ectopically expressed in HeLa cells and therefore could not be used to
address this question. The results suggest a role for Ser-764
phosphorylation in regulating dynII localisation during cytokinesis.
To test whether dynII phosphorylation is involved in cytokinesis,
we examined multinucleation, which is a characteristic of failedcytokinesis. The phospho-mimetic dynII759–775EE peptide signiﬁcant-
ly increased multinucleation, indicating cytokinesis failure due to
displacement of dynII rather than CaN (Fig. 6C). The phospho-
deﬁcient peptides from either dynII or dynI were without effect,
suggesting that the observation is speciﬁc. We initially chose the EE
mutant to increase the net negative charge in this region since
phosphorylation carries two negative charges while E mutants carry
only one. Similar results were obtainedwith an identical dynII peptide
wherein only the Ser-764 was mutated (Fig. 6D, peptides are named
AT or ET to indicate that the Thr-766 is wild-type). This is consistent
with the major role being ascribed only to the Ser-764 phosphosite.
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at Ser-764 and cytokinesis by an independent approach. Again, full
length GFP–dynII did not target the midbody when ectopically
expressed in HeLa cells. Therefore, it could not be used to address
the question. However, analogous to endogenous dynII, the dynII–
PRD region (GFP–dynII–PRD) when ectopically expressed, localised to
the midbody. Overexpression of this form of dynII containing
phospho-mimetic mutations (S764E or S764E/T766E) caused a
speciﬁc increase in multinucleation compared to the equivalent
phospho-deﬁcient (S764A or S764A/T766A) and wild-type forms
(Fig. 6E). This conﬁrms that Ser-764, not Thr-766, is the phosphosite
that is associated with cytokinesis in a cellular context. The results
suggest that dynII phosphorylation is important for cytokinesis.
4. Discussion
CaN triggers events late in mitosis that appear to trigger cellular
abscission at the end of cytokinesis [18]. This involves dephosphor-
ylation of dynII and potentially many other CaN substrates at the
midbody. DynII has recently been shown to be mitotically phosphor-
ylated on Ser-764 and/or Thr-766 [19]. We have now signiﬁcantly
extended these observations by showing that dynII is phosphorylated
exclusively at Ser-764 speciﬁcally during mitosis and that this
phosphosite appears to be involved in cytokinesis rather than
endocytosis or centrosome cohesion. Thus, phosphorylation switches
the function of dynII from a traditional to a novel role. Our ﬁndings
strongly suggest that not just CaN but CaN-mediated dynII dephos-
phorylation is an essential molecular component of cytokinesis, as
CaN alone at themidbody is insufﬁcient to complete cytokinesis in the
absence of dynII. To our surprise, dynII phosphorylation did not affect
other known biological roles for dynII such as CME or bulk
endocytosis, suggesting that phosphorylation is speciﬁc to its
cytokinesis role. This is surprisingly analogous to dynI, the phosphor-
ylation of which switches the function of dynI from clathrin-
dependent synaptic vesicle endocytosis to activity-dependent bulk
endocytosis in neurons [6,11,12]. Our ﬁndings suggest that phos-
phorylation of dynamin directs it to a new role in cytokinesis that is
independent of its well-characterised role in classical endocytosis.
This is the ﬁrst report of directly validated dynII phosphorylation
on serine or threonine residues. Mass spectrometry analysis suggests
that there is only a single phosphosite in dynII at the onset of mitosis,
although non-detectable minor sites may exist, strongly contrasting
to multi-site phosphorylation of dynI and III in neurons [9].
Phosphorylation at Ser-764 was independently conﬁrmed by three
approaches: MS analysis on dynII in rat lung, HeLa cells and using
phosphosite-speciﬁc antibodies. Neither dynI protein nor phosphor-
ylation of its abundant site at Ser-774 was detected with any
approach. No dynII phosphorylation on tyrosine was detected in our
study, but this cannot be ruled out due to its lability. In contrast, other
studies suggest a role for tyrosine phosphorylation at the Golgi during
vesicle trafﬁcking [17], which is normally stopped during mitosis but
resumes during cytokinesis [36–38]. Given that dynI is phosphory-
lated on 7 sites and dynIII on 3 sites in synaptosomes [9], it is perhaps
surprising that we found only 1 phosphosite in dynII in rat lung or
HeLa cells within methodological detection limits, despite our
extensive efforts to search for more. Mono-phosphorylation of a
protein in cells is far less common than multi-site phosphorylation.
However, among the phosphosites identiﬁed in the other classical
dynamins, only two (Ser-347/778) are conserved in the sequence of
dynII (as dynII-347 and Ser-764). Ser-347 does not have the amino
acid consensus motif required for mitotic phosphorylation, resides in
an acidic amino acid environment (IEGSGDQVD) and is the lowest
abundance site in dynI. Therefore, it is not surprising that its
phosphorylation in rat lungs or HeLa cells was undetectable.
Two large-scale phosphoproteomic studies reported that dynII
from mitotic cells is phosphorylated on a single tryptic phospho-peptide (dynII731–769), in agreement with our work [22,23]. However,
these studies listed all four phosphorylatable sites (S/T/Y) between
Ser-761 and Thr-766 as phosphorylated in HeLa cells (the tryptic
peptide is EALNIIGDISTSTVSTPVPPPVDDTWLQSASSHpSPTPQR731–769,
sites are underlined; Ser-764 is in bold). All four phosphosite results
were subsequently transferred to a public phosphosite database
(www.phosphosite.org). We believe that these sites in dynII were
prematurely given the status of genuine phosphorylation sites. Ser-
764 is the only genuine phosphosite and evidence supports this
conclusion (see Supplementary information for a detailed discussion).
Our phosphosite assignment has been validated by detection of
phospho-dynII–Ser-764 using phospho-speciﬁc antibodies to this site
both after in vitro phosphorylation and in cells. Additionally, the
recombinant form of dynII where this site was mutated to Ala lost over
80% of its in vitro phosphorylation by cdk, indicating that Ser-764 is the
main phosphosite in vitro as well as in cells. Finally, endogenous dynII
did not localise to the midbody in cells treated with the dynII phospho-
mimetic peptide whereby only the Ser-764wasmutated to Glu and the
Thr-766 was wild-type (data not shown), indicating that the functional
role is only for Ser-764 in cells. Note that in vitro phosphosites are only
indicative of phosphosites that might be found in cells but cannot be
used as evidence for the presence or not of that site in cells.
The mitotic phosphorylation site in dynII clearly did not play an
essential role in CME or bulk endocytosis as determined by two
independent strategies of peptide competition and siRNA depletion/
rescue. For example, we found that both phospho-deﬁcient and
phospho-mimetic GFP–dynII constructs could completely rescue CME.
This is consistent with the known ability of such wild-type constructs
to rescue endocytosis [1] and suggests that Ser-764 is not required.
This observation is consistent with recent studies on mitotic
endocytosis. At least three other endocytic proteins are phosphory-
lated upon mitotic entry: epsin, eps15 and amphiphysin I. While their
phosphorylation in nerve terminals appears to be related to inhibiting
their role in endocytosis until they are dephosphorylated by
calcineurin, they were originally proposed to be mitotically phos-
phorylated in order to inhibit endocytosis during mitosis. However, a
recent study suggests that endocytosis is not speciﬁcally inhibited in
mitotic cells [39]. This suggests that mitotic phosphorylation of key
endocytic proteins may be a common mitotic event with a role in
functions other than endocytosis. In support of this idea, epsin induces
membrane curvature for proper mitotic spindle organisation and this
role is independent of its endocytic function and mitotic phosphor-
ylation [40]. In an analogous manner to dynII–Ser-764, it is also
possible that these other mitotically phosphorylated endocytic
proteins might prove to be CaN targets during cytokinesis.
Phosphorylation of dynII at Ser-764 in the phospho-box region by
cdk1 coincided with its localisation to the centrosome where it
resided until late in mitosis. It is unclear whether there is any role for
phosphorylation here since we observed no speciﬁc centrosome
defects in dynII-depleted cells (data not shown). Like dynII, many
other proteins are phosphorylated upon mitotic entry and locate to
the mitotic centrosome [41]. This localisation is thought to be driven
by phosphorylation. However, our data suggest that Ser-764 phos-
phorylation is not required for targeting dynII to the mitotic
centrosome. This is consistent with previous ﬁndings demonstrating
that the dynamin middle domain binds the centrosome component,
γ-tubulin [3]. We conﬁrmed that the middle domain of dynII, when
fused to GFP, targets the centrosome, while the full length protein did
not. This suggests that full length dynII constructs (GFP or Flag-
tagged) do not fully mimic all of the biological roles of endogenous
dynII. Many cytokinesis proteins, such as Cep55, reside at the
centrosome during mitosis without any known centrosome role
[41,42]. The role of phospho-dynII on the mitotic centrosome is
unclear; however, one possibility is that it is an intermediate
“holding” location for certain proteins that are involved in later
mitotic events. In contrast to phospho-dynII, CaN does not locate to
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phospho-dynII may provide a mechanism of physically separating it
from CaN at this point in mitosis. For example, Ca2+ activates CaN and
acts at a second point in mitosis, prior to cytokinesis during anaphase
progression [43,44]. The lack of CaN/dynII colocalisation at this stage
may conceivably protect dynII from being prematurely dephosphory-
lated and hence triggering mitotic exit prematurely.
Collectively, our observations highlight a molecular signalling
pathway that is associated with completion of the abscission stage
of cytokinesis that involves Ca2+, CaN and phospho-dynII–Ser-764.
This is strikingly analogous to dynI where an analogous signalling
pathway and phosphosites regulate the switching of the standard
synaptic vesicle endocytic mode to a second unique bulk endocy-
tosis role [6,11,12]. Our two recent discoveries demonstrate that
CaN activity [18] and dynII [1,2,4,34,35] are required for the
completion of the abscission stage of cytokinesis. Here, we now
show that it is the phosphorylated form of dynII that is a key part of
the cytokinesis mechanisms downstream of CaN rather than playing
a role in endocytosis. We found phospho-dynII is concentrated at
the midbody at the time of cytokinesis [18]. In contrast to the
centrosome, this localisation was disrupted by the phospho-mimetic
peptides but not by phospho-deﬁcient peptides. It is possible that
Ser-764 phosphorylation is a signal to target or tether dynII to the
midbody during cytokinesis with its dephosphorylation releasing it
into partnership with a speciﬁc, as yet unidentiﬁed, phospho-
dependent binding partner. The phospho-mimetic peptides specif-
ically induced cytokinesis failure, as indicated by a signiﬁcant
increase in multinucleation, a primary characteristic of failed
cytokinesis. The dynII phospho-mimetic peptides had no effect on
CaN midbody localisation; thus, CaN alone at the midbody is not
sufﬁcient to complete cytokinesis. Instead, these ﬁndings collective-
ly suggest that CaN-mediated dephosphorylation of dynII–Ser-764 is
associated with successful completion of cytokinesis. We also found
that a GFP–dynII–PRD construct targeted the midbody and that cells
expressing GFP–dynII–PRD phospho-mimetic mutants, not phos-
pho-deﬁcient mutants, increased cytokinesis failure. Overall, our
data show that dynII is mitotically phosphorylated primarily on a
single site, Ser-764 by cdk, and that this phosphorylation site is not
involved in endocytosis or centrosome cohesion but rather in the
regulation of cytokinesis.
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